Insmed (INSM) Other Non-Current Assets (2011 - 2026)

Insmed (INSM) recorded quarterly Other Non-Current Assets of $99.3 million in Q1 2026, up 1.95% quarter-over-quarter from $97.4 million in Q4 2025, and up 10.6% on a YoY basis from $89.8 million in Q1 2025.

Insmed (INSM) Other Non-Current Assets (2011 - 2026) Analysis & Trends

Insmed's Other Non-Current Assets history runs 16 years deep, the most recent figure standing at $99.3 million for Q1 2026.

  • In Q1 2026, Other Non-Current Assets rose 10.6% year-over-year to $99.3 million; the TTM figure through Mar 2026 stood at $99.3 million (up 10.6% YoY), while the FY2025 annual figure was $97.4 million, up 4.45% from the prior year.
  • Other Non-Current Assets was $99.3 million for Q1 2026 at Insmed, up from $97.4 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $99.3 million in Q1 2026 to a low of $57.2 million in Q1 2022.
  • Historically, Other Non-Current Assets has averaged $85.6 million across 5 years, with a median of $89.8 million in 2025.
  • The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets surged 49.25% in 2022, then retreated 6.21% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $76.1 million in 2022, then gained by 26.9% to $96.6 million in 2023, then slipped by 3.47% to $93.2 million in 2024, then gained by 4.45% to $97.4 million in 2025, then increased by 1.95% to $99.3 million in 2026.
  • The last three Other Non-Current Assets figures came in at $99.3 million (Q1 2026), $97.4 million (Q4 2025), and $91.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 12.40 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - 60,000.00
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 1.26 Bn
9 Abivax 91.71 Bn 91.71 Bn - -
10 Insmed 19.79 Bn 18.57 Bn 258.54 Mn 99.28 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 99.28 Mn
Dec 31, 2025 97.38 Mn
Sep 30, 2025 91.61 Mn
Jun 30, 2025 88.81 Mn
Mar 31, 2025 89.76 Mn
Dec 31, 2024 93.23 Mn
Sep 30, 2024 96.86 Mn
Jun 30, 2024 85.83 Mn
Mar 31, 2024 95.70 Mn
Dec 31, 2023 96.57 Mn
Sep 30, 2023 92.49 Mn
Jun 30, 2023 83.45 Mn
Mar 31, 2023 81.32 Mn
Dec 31, 2022 76.10 Mn
Sep 30, 2022 63.71 Mn
Jun 30, 2022 66.30 Mn
Mar 31, 2022 57.20 Mn
Dec 31, 2021 50.99 Mn
Sep 30, 2021 47.60 Mn
Jun 30, 2021 49.24 Mn